Xellia
1 known investors
Find your way into Xellia
2,110 people in our graph share verified history with the Xellia team — schools, employers, funds. One of them is your warm intro.
Kike Mirallesunlockedknows Alexander Sproedt · together at McKinsey & Company (overlapped)
×6knows the team · via McKinsey & Company
×4knows the team · via PwC
knows the team · via Karlsruhe Institute of Technology (KIT)
Xellia manufactures anti-infective pharmaceutical products with a focus on supply chain continuity and reliable availability of critical active pharmaceutical ingredients in Western markets.
Founders & leadership
MK
Michael KocherinCEOMichael Kocher is CEO of Xellia, an anti-infective pharmaceutical manufacturer focused on supply chain continuity for critical active pharmaceutical ingredients. He has held various leadership roles across multiple companies and industries.
AS
Alexander SproedtinChief Operations OfficerAlexander Sproedt is Chief Operations Officer of Xellia, where he oversees Manufacturing, Supply Chain Management, Quality, Regulatory Affairs, Engineering, and Technology Transfer. He previously spent 10 years as a Partner at McKinsey & Company's Zurich office, leading transformations for Life Sciences and consumer goods companies with focus on procurement, supply chain management, and external manufacturing.
GB
Gaël BernardinChief Commercial OfficerGaël Bernard is Chief Commercial Officer at Xellia Pharmaceuticals, where he oversees global commercial strategy for anti-infective products. He has held international business development and revenue growth leadership roles and serves as a board member of a Xellia joint venture with Zhejiang Hisun Pharmaceutical Company.
VO
Vicente OllerinChief Financial Officer
AF
Art FioccoinChief Quality OfficerHe has held leadership roles in pharmaceutical operations, quality management, manufacturing, and organizational transformation.
LH
Linda Haugaard-KedströmChief Scientific Officer
FF
Florian Falch
Investors · 1
In the news
Frequently asked questions
- What does Xellia do?
- Xellia manufactures anti-infective pharmaceutical products with a focus on supply chain continuity and reliable availability of critical active pharmaceutical ingredients in Western markets.
- Who are Xellia's investors?
- Xellia's investors include 3i Group.
- Where is Xellia headquartered?
- Xellia is headquartered in Unknown, EU.